Possible Implications of the Inflation Reduction Act for Oncology Products and Stakeholders

In this episode, we discuss potential implications of the Inflation Reduction Act (IRA) legislation that was passed in the U.S. in 2022.

This episode covers:

• An overview of the IRA in relation to healthcare
• The potential impacts for oncology patients, manufacturers, and oncologists
• The impact of the legislation outside of the U.S.

Speakers:

• Nancy McGee, JD, MPH, DrPH, Senior Vice President, Health Policy & Public Payers, Lumanity
• Rob Rawlinson, Director, Oncology Insights Lead, Lumanity

©2023 Lumanity Inc.